Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia

A technology for aplastic and leukemia, applied in blood diseases, drug combinations, anti-tumor drugs, etc., can solve problems such as unsatisfactory curative effect, no specific therapeutic drugs, unsatisfactory curative effect, etc.

Inactive Publication Date: 2003-06-11
刘钦
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chinese patent CN95113751.4 discloses a kind of Tuimoside A extracted from the traditional Chinese medicine Tuibei Mu, which has the effect of killing leukemia cells and inducing the differentiation of leukemia cells, but the curative effect is not ideal
Chinese patent application 9915402.9 discloses a traditional Chinese medicine preparation composed of lotus seed heart and astragalus for anti-leukemia and reversing drug resistance.
Currently, there is no specific drug for the treatment of aplastic anemia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0004] Example 1: Weigh 1.5 kg of Lobelia, 1 kg of Qingdai, 1.5 kg of Astragalus, 2 kg of Hedyotis diffusa, 1.5 kg of Silver Flower, 1.5 kg of Codonopsis, 0.7 kg of Scrophulariae, 1 kg of Scrophulariae, 1 kg of Agrimony, Banlangen 2kg, Habitat 1.5kg, Ophiopogon japonicus 1kg, Forsythia 1kg, Chinensis 1.5kg, Poria cocos 1kg, Danpi 1kg, Salvia miltiorrhiza 1kg, Houttuynia cordata 1.5kg, Ejiao 1kg, Coptis 1kg. The herbs in the above-mentioned medicinal materials should be pre-treated by drying in the sun and removing impurities. After mixing, mix well, pulverize, and pass through a No. 4 sieve to form a powder. The daily dosage for adults is 200 grams, the daily dosage for children over 10 years old is 150 grams, and the daily dosage for children under 10 years old is 100 grams, which can be packaged according to the actual needs of taking medicine. Dosage: wrapped in gauze, decocted in water, 3 times a day. The medicine of this embodiment is suitable for the treatment of acute...

Embodiment 2

[0005] Example 2: Weigh the following medicinal materials: 1.5 kg of Lobelia, 1 kg of Qingdai, 1.5 kg of Astragalus, 2 kg of Hedyotis diffusa, 1.5 kg of Silver Flower, 1.5 kg of Codonopsis, 0.7 kg of Scrophulariae, 1 kg of Scrophulariae, Agrimony 1kg, Banlangen 1kg, Habitat 1kg, Ophiopogon japonicus 1kg, Forsythia 1kg, Chinensis 1.5kg, Poria cocos 1kg, Danpi 1kg, Salvia miltiorrhiza 1kg, Houttuynia cordata 2kg, Ejiao 1kg, Coptis 1kg kg, 2 kg of buffalo horn, 1.5 kg of Anemarrhena, 1.5 kg of mast, and 3 kg of raw gypsum. The herbs in the above-mentioned medicinal materials should be pre-treated by drying in the sun and removing impurities. Mix the above medicinal materials, mix well, pulverize, and pass through a No. 4 sieve to form a powder. The daily dosage for adults is 250 grams, the daily dosage for children over 10 years old is 200 grams, and the daily dosage for children under 10 years old is 150 grams. It can be packaged separately according to actual treatment needs....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses a Chinese medicine for curing leukemia and aplastic anemia. It is made from 20 Chinese medicinal materials of Chinese lobelia, indigo, astragalus root, hedyotis, lonicera flower, codonopsis, root and others. It can be made into various dosage forms of powder, pill, tablet and paste preparation, and its effective rate can be up to above 90%, after three months for curing leukemia its curative rate is up to above 50%. For aplastic anemia it has specific effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation for treating acute and chronic leukemia and aplastic anemia. Background technique [0002] At present, the most effective way to treat leukemia is bone marrow, umbilical cord blood or hematopoietic stem cell transplantation. However, due to the limited sources of suitable bone marrow, umbilical cord blood, and hematopoietic stem cells, the operation is highly dependent on technology and equipment, and the cost is as high as hundreds of thousands of yuan. , so its application is subject to many restrictions. Although some symptoms can be alleviated by chemotherapy and radiotherapy, they cannot be cured, and the toxicity and side effects are large. There are also Chinese medicine treatments. Chinese patent CN95113751.4 discloses a kind of soil frillimoside A extracted from the traditional Chinese medicine Fritillaria japonicus, which has the effect of killing leukemia cells and inducin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/06A61K35/32A61K35/36A61P7/06A61P35/02
Inventor 刘钦
Owner 刘钦
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap